Probiotics in non-alcoholic fatty liver disease: which and when



Document title: Probiotics in non-alcoholic fatty liver disease: which and when
Journal: Annals of hepatology
Database: PERIÓDICA
System number: 000416105
ISSN: 1665-2681
Authors: 1
2
3
4
1
Institutions: 1Universita Magna Graecia, Dipartimento di Scienze della Salute, Catanzaro, Calabria. Italia
2Universita La Sapienza, Dipartimento di Pediatria, Roma, Lazio. Italia
3University Hospital Center Touhami Benflis, Department of Internal Medicine, Batna. Argelia
4Consiglio Nazionale delle Ricerche, istituto, Roma, Lazio. Italia
Year:
Volumen: 12
Number: 3
Pages: 357-363
Country: México
Language: Inglés
Document type: Revisión bibliográfica
Approach: Analítico
English abstract Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently suggests that the microbiota is a casual factor of the disease, involved in the interactions between intestinal lumen and liver. Probiotic are commensal bacteria, able to modulate the microbiota with benefits for the health of humans. Several data suggest a range of potentially beneficial medicinal uses for probiotics, in particular in NAFLD patients. However, the species with higher efficacy in this disease are not identified. The present review focuses on the role of gut-liver axis in the pathogenesis, and on the potential therapeutic role of probiotics in the managing of NAFLD
Disciplines: Medicina
Keyword: Gastroenterología,
Terapéutica y rehabilitación,
Microbiota intestinal,
Permeabilidad intestinal,
Probióticos,
Hígado graso no alcohólico,
Patogénesis,
Eje intestino-hígado
Keyword: Gastroenterology,
Therapeutics and rehabilitation,
Intestinal microbiota,
Intestinal permeability,
Probiotics,
Non alcoholic fatty liver,
Pathogenesis,
Gut-liver axis
Full text: Texto completo (Ver PDF)